Document is current
Any future updates will be listed below
-
Authors
Fu, Liyan
Li, Chenxuan
Ni, Jun
Qian, Jin
Xiao, Jian
Zhu, Qiong
Huang, Shouwei
Xiong, Jinfeng
Chen, Qi
Guan, Xuhua
Fang, Rui
Fen, Du
Tang, Shuang
Deng, Fei
Liu, Dan
Shen, Shu
Wu, Xiaoli
-
Funding
Funding for this research was provided by:
Hubei Province Public Health Leading Talent Program
National Disease Control and Prevention Administration Public Health Talent Cultivation Support Program
National Natural Science Foundation of China (U21A20180)
Innovative Research Group Project of Hubei Provincial Natural Science Foundation (2025AFA036)
the Key Project of Key Laboratory of Virology and Biosafety in the Wuhan Institute of Virology (2024JZZD-02-FD)
National Key R&D Program of China (2022YFC2305100)
- License Information
-
More Information
Article History
Received: 12 November 2025
Accepted: 21 January 2026
First Online: 9 March 2026
Declarations
:
: All experiments involving infectious agents are conducted under Biosafety Level 2 (BSL-2) laboratory conditions. All animal experiments were conducted in Animal Biosafety Level 2 (ABSL-2) laboratory. The animal experimental protocols were approved by the Ethics Committee of the Wuhan Institute of Virology, Chinese Academy of Sciences (approval no. WIVA33202102).
: Not applicable.
: The authors declare no competing interests.
